{
    "body": "What are the symptoms of abacavir hypersensitivity?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12719670", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12869229", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18855539", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17245797"
    ], 
    "triples": [
        {
            "p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/class", 
            "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/1297", 
            "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseaseClass/Immunological"
        }, 
        {
            "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", 
            "s": "http://linkedlifedata.com/resource/umls/label/A12061804", 
            "o": "http://www.w3.org/2008/05/skos-xl#Label"
        }, 
        {
            "p": "http://www.w3.org/2008/05/skos-xl#prefLabel", 
            "s": "http://linkedlifedata.com/resource/umls/id/C1840547", 
            "o": "http://linkedlifedata.com/resource/umls/label/A12061804"
        }, 
        {
            "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", 
            "s": "http://linkedlifedata.com/resource/umls/label/A11948761", 
            "o": "http://www.w3.org/2008/05/skos-xl#Label"
        }, 
        {
            "p": "http://www.w3.org/2008/05/skos-xl#literalForm", 
            "s": "http://linkedlifedata.com/resource/umls/label/A11994170", 
            "o": "ABACAVIR HYPERSENSITIVITY, SUSCEPTIBILITY TO"
        }, 
        {
            "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", 
            "s": "http://linkedlifedata.com/resource/umls/label/A17030126", 
            "o": "http://www.w3.org/2008/05/skos-xl#Label"
        }, 
        {
            "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type", 
            "s": "http://linkedlifedata.com/resource/umls/label/A7589770", 
            "o": "http://www.w3.org/2008/05/skos-xl#Label"
        }, 
        {
            "p": "http://www.w3.org/2008/05/skos-xl#altLabel", 
            "s": "http://linkedlifedata.com/resource/umls/id/C1457887", 
            "o": "http://linkedlifedata.com/resource/umls/label/A7589770"
        }
    ], 
    "ideal_answer": [
        "Patients receiving abacavir develop an idiosyncratic hypersensitivity reaction that can include a wide range of symptoms. The most common are: fever, enathema, skin rash, nausea, vomiting, diarrhoea, cough, gastrointestinal disorders, anaphylactic shock, respiratory symptoms."
    ], 
    "exact_answer": [
        [
            "fever"
        ], 
        [
            "enathema"
        ], 
        [
            "skin rash"
        ], 
        [
            "nausea"
        ], 
        [
            "vomiting"
        ], 
        [
            "diarrhea"
        ], 
        [
            "cough"
        ], 
        [
            "gastrointestinal disorders"
        ], 
        [
            "anaphylactic shock"
        ], 
        [
            "respiratory symptoms"
        ]
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004342", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006967", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0002524", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012816", 
        "http://www.biosemantics.org/jochem#4274474", 
        "http://www.biosemantics.org/jochem#4239946", 
        "http://www.biosemantics.org/jochem#4274473"
    ], 
    "type": "list", 
    "id": "51542dc3d24251bc0500007e", 
    "snippets": [
        {
            "offsetInBeginSection": 148, 
            "offsetInEndSection": 286, 
            "text": "patients receiving abacavir develop a hypersensitivity reaction, characterized by rash, fever and, occasionally, multisystemic involvement", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18855539", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 861, 
            "offsetInEndSection": 1127, 
            "text": "The predictors included any one of several specific symptoms commonly found with this reaction, a claims diagnosis of adverse effect of drug, anaphylactic shock or unspecified allergy, and a discontinuation in abacavir prior to completing a 90-day course of therapy.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17245797", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 176, 
            "offsetInEndSection": 615, 
            "text": "patients who receive abacavir develop an idiosyncratic hypersensitivity reaction. The most common symptoms are fever, skin rash and gastrointestinal disorders. Respiratory symptoms occurred in approximately 20% of patients who have hypersensitivity reaction. We describe the first case, to our knowledge, of hypesensitivity reaction characterized by enanthema and fever without skin rash promptly resolved after discontinuation of abacavir", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12719670", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 11, 
            "offsetInEndSection": 161, 
            "text": "Abacavir is associated with an infrequent but potentially serious hypersensitivity reaction (HSR) that can include a wide range of signs and symptoms.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17245797", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 229, 
            "offsetInEndSection": 515, 
            "text": "Rash was associated with hypersensitivity (odds ratio [OR] = 13.1, P = 0.02) as was the presence of nausea (OR = 30, P < 0.001), vomiting (OR = 17.1, P = 0.001) or diarrhoea (OR = 22, P < 0.001). The number of gastrointestinal symptoms was also predictive of hypersensitivity reaction (", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12869229", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 747, 
            "offsetInEndSection": 957, 
            "text": "the number of gastrointestinal symptoms (OR = 8.6, P = 0.0032), cough (OR = 0.039, P = 0.02) and rash (OR = 16.9, P = 0.07). Abacavir hypersensitivity is strongly associated with gastrointestinal (GI) symptoms.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12869229", 
            "endSection": "sections.0"
        }
    ]
}